In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.

CRISPR Therapeutics AG. Trade Record

NASDAQ:CRSP CRISPR Therapeutics AG stock gains 21.82% Exit May 31, 2018 a Trade Record by priceseries

Trade Chart
Trade Chart CRSP May 10, 2018, priceSeries
About CRISPR Therapeutics AG

CRISPR Therapeutics AG focuses on the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 gene-editing platform. The CRISPR/Cas9 technology allows for changes to genomic DNA. The company has strategic collaborations with Bayer AG and Vertex Pharmaceuticals to develop CRISPR-based therapeutics in other diseases. It operates in Switzerland, the United States, and the United Kingdom. CRISPR Therapeutics AG is headquartered in Basel, Switzerland.

Trade Information
Trade Type
LONG
ReliabilityScore™
99.60
Entry Date
May 10, 2018
Entry Price
52.12
Sell Date
May 31, 2018
Sell Price
63.49
Net Gain
21.82%
Hold Time
14 Trading Days